Financials Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi

Equities

KLKIM

TREKLKM00025

Commodity Chemicals

Market Closed - Borsa Istanbul 11:09:50 2024-04-26 am EDT 5-day change 1st Jan Change
26.1 TRY +1.32% Intraday chart for Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi -4.04% +21.40%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025
Capitalization 1 2,082 5,729 9,890 12,006 -
Enterprise Value (EV) 1 2,082 5,265 9,890 12,006 12,006
P/E ratio 977 x 10.9 x - - -
Yield - 2.01% - - -
Capitalization / Revenue - 2,673,153 x 2,118,645 x - -
EV / Revenue - 2,673,153 x 2,118,645 x - -
EV / EBITDA - 12.7 x 9.73 x 10.9 x 8.41 x
EV / FCF - 34.7 x - 21.4 x -
FCF Yield - 2.88% - 4.68% -
Price to Book - 5.34 x - - -
Nbr of stocks (in thousands) 460,000 460,000 460,000 460,000 -
Reference price 2 4.525 12.46 21.50 26.10 26.10
Announcement Date 3/1/22 3/2/23 4/17/24 - -
1TRY in Million2TRY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025
Net sales - 2,143 4,668 - -
EBITDA 1 - 451.6 1,016 1,100 1,427
EBIT 1 - 421.7 894.6 1,035 1,347
Operating Margin - 19.67% 19.17% - -
Earnings before Tax (EBT) 1 - 508 652 1,279 1,569
Net income 213.3 506.9 430.4 - -
Net margin - 23.65% 9.22% - -
EPS 0.004630 1.140 - - -
Free Cash Flow 1 - 165 - 562 -
FCF margin - 7.7% - - -
FCF Conversion (EBITDA) - 36.55% - 51.09% -
FCF Conversion (Net income) - 32.56% - - -
Dividend per Share - 0.2500 - - -
Announcement Date 3/1/22 3/2/23 4/17/24 - -
1TRY in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 302.4 555.5 560.9 724.5 602.2 848.1 1,095
EBITDA 1 - 112.8 106.3 157.8 108.1 217.4 304.6
EBIT - - - - - - -
Operating Margin - - - - - - -
Earnings before Tax (EBT) 1 - - 107.2 186.8 121.5 289.9 330
Net income 1 71.1 110.3 83.98 241.5 94.03 229.4 244.8
Net margin 23.51% 19.85% 14.97% 33.34% 15.61% 27.04% 22.36%
EPS - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 4/21/22 8/9/22 10/18/22 3/2/23 5/1/23 8/9/23 10/20/23
1TRY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025
Net Debt - - - - -
Net Cash position - 464 - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 - 165 - 562 -
ROE (net income / shareholders' equity) - 59% - - -
ROA (Net income/ Total Assets) - 36.4% - - -
Assets - 1,391 - - -
Book Value Per Share - 2.330 - - -
Cash Flow per Share - - - - -
Capex - 87.6 - - -
Capex / Sales - 4.09% - - -
Announcement Date 3/1/22 3/2/23 4/17/24 - -
1TRY in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
26.1 TRY
Average target price
32.73 TRY
Spread / Average Target
+25.40%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. KLKIM Stock
  4. Financials Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi